Published in Postgrad Med on November 01, 2010
A Review of Nebivolol Pharmacology and Clinical Evidence. Drugs (2015) 0.81
Modifying Risk Factors in the Management of Erectile Dysfunction: A Review. World J Mens Health (2016) 0.77
Long-term treatment of clonidine, atenolol, amlodipine and dihydrochlorothiazide, but not enalapril, impairs the sexual function in male spontaneously hypertensive rats. PLoS One (2015) 0.75
[An invasive strategy in non-ST-segment elevation acute coronary syndromes. From large trials to the real world]. Rev Esp Cardiol (2004) 2.03
Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovasc Ther (2010) 1.48
Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome. Catheter Cardiovasc Interv (2013) 1.46
Impact of new criteria for anticoagulant treatment in atrial fibrillation. Rev Esp Cardiol (2011) 1.44
GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function. Angiology (2012) 1.43
Low levels of high-density lipoproteins cholesterol are independently associated with acute coronary heart disease in patients hospitalized for chest pain. Rev Esp Cardiol (Engl Ed) (2011) 1.43
Nesfatin-1 in human and murine cardiomyocytes: synthesis, secretion, and mobilization of GLUT-4. Endocrinology (2013) 1.41
Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study. J Clin Hypertens (Greenwich) (2009) 1.40
[Sex differences in mortality at one-month and at one-year after an acute coronary syndrome]. Med Clin (Barc) (2004) 1.39
Effect of invasive treatment on prognosis in non-ST-segment elevation acute coronary syndrome with or without systolic dysfunction. Rev Esp Cardiol (2010) 1.39
[Treatment and control of cardiovascular risk in primary care in Spain. The PREVENCAT study]. Med Clin (Barc) (2006) 1.39
[Impact of blood pressure control on the ankle-brachial index in hypertensive patients]. Med Clin (Barc) (2012) 1.38
Ischemic heart disease in women. Data from BARIHD study. Rev Esp Cardiol (Engl Ed) (2012) 1.38
The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends Cardiovasc Med (2007) 1.17
Differential prognostic effect of systolic blood pressure on mortality according to left-ventricular function in patients with acute heart failure. Eur J Heart Fail (2010) 1.12
Predictive value of thromboembolic risk scores before an atrial fibrillation ablation procedure: time for a consensus? J Cardiovasc Electrophysiol (2013) 1.08
Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress. Am J Physiol Heart Circ Physiol (2010) 0.99
Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome. Rev Esp Cardiol (2010) 0.95
Doxazosin induces activation of GADD153 and cleavage of focal adhesion kinase in cardiomyocytes en route to apoptosis. Cardiovasc Res (2006) 0.91
Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? Heart (2006) 0.90
[Prognostic value of Charlson comorbidity index at 30 days and 1 year after acute myocardial infarction]. Rev Esp Cardiol (2004) 0.90
Differences in MEF2 and NFAT transcriptional pathways according to human heart failure aetiology. PLoS One (2012) 0.89
Increased expression of fatty-acid and calcium metabolism genes in failing human heart. PLoS One (2012) 0.88
Consensus document for the detection and management of chronic kidney disease. Nefrologia (2014) 0.88
Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome. Eur Heart J Acute Cardiovasc Care (2012) 0.87
Heart failure induces significant changes in nuclear pore complex of human cardiomyocytes. PLoS One (2012) 0.87
Cardioembolic stroke: call for a multidisciplinary approach. Cerebrovasc Dis (2009) 0.87
Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome: a proteomic study. PLoS One (2010) 0.87
Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens (2009) 0.87
Changes in lipid transport-involved proteins of epicardial adipose tissue associated with coronary artery disease. Atherosclerosis (2012) 0.87
Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction. Coron Artery Dis (2010) 0.86
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol (Engl Ed) (2016) 0.85
Heart failure entails significant changes in human nucleocytoplasmic transport gene expression. Int J Cardiol (2013) 0.85
[Permanent atrial fibrillation in heart disease in Spain. The CARDIOTENS study 1999]. Rev Esp Cardiol (2002) 0.85
High-sensitivity C-reactive protein is a predictor of in-hospital cardiac events in acute myocardial infarction independently of GRACE risk score. Angiology (2011) 0.85
Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. Am J Cardiol (2009) 0.84
Differential gene expression of cardiac ion channels in human dilated cardiomyopathy. PLoS One (2013) 0.84
Inflammation and apoptosis in hypertension. Relevance of the extent of target organ damage. Rev Esp Cardiol (Engl Ed) (2012) 0.83
High-resolution two-dimensional gel electrophoresis analysis of atrial tissue proteome reveals down-regulation of fibulin-1 in atrial fibrillation. Int J Cardiol (2010) 0.83
Burden of systemic hypertension in patients admitted to cardiology hospitalization units. Am J Cardiol (2011) 0.83
Pulse wave velocity and digital volume pulse as indirect estimators of blood pressure: pilot study on healthy volunteers. Cardiovasc Eng (2009) 0.83
Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis (2008) 0.83
Differences in medical treatment of chronic coronary heart disease patients according to medical specialities. Cardiovasc Ther (2009) 0.83
Usefulness of the fractional flow reserve derived by intracoronary pressure wire for evaluating angiographically intermediate lesions in acute coronary syndrome. Rev Esp Cardiol (2010) 0.83
High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction. Rev Port Cardiol (2013) 0.82
[Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease]. Rev Esp Cardiol (2011) 0.81
Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ damage. J Hypertens (2013) 0.81
Prognostic effect of renal dysfunction after ST-segment elevation myocardial infarction with and without heart failure. Int J Cardiol (2005) 0.81
Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction. World J Cardiol (2012) 0.81
Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine. Int J Cardiol (2005) 0.80
Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction. Thromb Haemost (2014) 0.80
Comparison of effectiveness of high-dose intracoronary adenosine versus intravenous administration on the assessment of fractional flow reserve in patients with coronary heart disease. Am J Cardiol (2013) 0.80
Prognostic differences between routine invasive and conservative strategies for the management of high-risk, non-ST segment acute coronary syndromes: Experience from two consecutive periods in a single center. Eur J Intern Med (2007) 0.80
Safety and efficacy of coronary drug-eluting stents in octogenarians. Rev Esp Cardiol (2009) 0.79
Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes. Am Heart J (2005) 0.79
[Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: the ICP-bypass study]. Rev Esp Cardiol (2011) 0.79
[Knowledge and implementation of cardiovascular risk clinical practice guidelines by general practitioners and specialists]. Rev Esp Cardiol (2006) 0.79
[Prognostic value of white blood cell count in acute myocardial infarction: long-term mortality]. Rev Esp Cardiol (2005) 0.79
Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged >or=65 years. The FAPRES trial. Rev Esp Cardiol (2010) 0.79
Bioelectrical impedance vector analysis and clinical outcomes in patients with acute heart failure. J Cardiovasc Med (Hagerstown) (2016) 0.79
Anticoagulation prescription in atrial fibrillation. Expert Opin Pharmacother (2011) 0.79
Variations in platelet proteins associated with ST-elevation myocardial infarction: novel clues on pathways underlying platelet activation in acute coronary syndromes. Arterioscler Thromb Vasc Biol (2011) 0.79
Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years. Rev Port Cardiol (2013) 0.79
Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES. Rev Esp Cardiol (2010) 0.78
Differential association of S100A9, an inflammatory marker, and p53, a cell cycle marker, expression with epicardial adipocyte size in patients with cardiovascular disease. Inflammation (2014) 0.78
[Global treatment of cardiovascular risk in the hypertensive patient]. Rev Esp Cardiol (2007) 0.77
[Gender differences in patients with suspected non-ST-segment elevation acute coronary syndromes. Implications for invasive management]. Rev Esp Cardiol (2003) 0.77
RNA sequencing analysis identifies new human collagen genes involved in cardiac remodeling. J Am Coll Cardiol (2015) 0.77
Pathological ankle-brachial index is equivalent of advanced age in acute coronary syndromes. Eur J Clin Invest (2011) 0.77
Mean platelet volume is associated with infarct size and microvascular obstruction estimated by cardiac magnetic resonance in ST segment elevation myocardial infarction. Blood Coagul Fibrinolysis (2013) 0.77
[Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure]. Rev Esp Cardiol (2011) 0.77
Role of dihydropyridinic calcium channel blockers in the management of hypertension. Expert Rev Cardiovasc Ther (2013) 0.77
Short-term metabolic changes achieved by weight loss in hypertensive patients. Int J Cardiol (2010) 0.76
Control of risk factors in and treatment of patients with coronary heart disease: the TRECE study. Rev Esp Cardiol (2009) 0.76
High-density lipoproteins after acute coronary syndromes: evaluation of residual risk. Rev Esp Cardiol (Engl Ed) (2012) 0.76
[How beta-blockers are used in Spain? Analysis of limitations in their use in internal medicine and cardiology: CARACTER-BETA study]. Rev Esp Cardiol (2011) 0.76
Renal transplantation in the elderly: does patient age determine the results? Age Ageing (2005) 0.76